Influenza immunostimulating complexes (flu-ISCOMs) and a monovalent subvirion vaccine prepared with an H1N1 strain of influenza virus were compared in mice for immunogenicity and protection against challenge with homologous and heterotypic influenza viruses. flu-ISCOMs but not subvirion vaccine fully protected mice against homologous virus challenge after one immunization as assessed by measurement of virus lung titers. The improved protection induced by flu-ISCOMs was associated with a 10-fold higher prechallenge serum hemagglutination inhibition titer. Furthermore, only flu-ISCOMs fully protected mice against mortality and reduced morbidity following challenge with an influenza virus of the serologically distinct H2N2 subtype. This cross-protection correlated with the induction of virus cross-reactive cytotoxic T lymphocytes that recognized a known major histocompatibility class I (H2-K d ) -restricted epitope within the hemagglutinin of influenza virus that is conserved among the H1 and H2 influenza virus subtypes. flu-ISCOMs may offer significant advantages over current commercial formulations as an improved influenza vaccine.
The development of improved vaccines against influenza cacious than the current vaccines. These strategies include the use of alternative delivery vehicles for influenza virus antigens, virus is an acknowledged goal in vaccinology [1] . Current influenza vaccines are Ç70% effective at preventing illness in such as liposomes [8] and oil-in-water emulsions [9] , formulation in adjuvants [10] , and cDNA encoding various viral prohealthy adults [2] and Ç50% effective at preventing hospitalization and pneumonia in persons §65 years old [3] . The deteins [11, 12] . An alternative approach would be to use immunostimulating complexes (ISCOMs), an adjuvanted particulate sired properties of an improved influenza vaccine are production of increased titers of virus-neutralizing antibodies against vaccine system comprising cholesterol, phospholipid, antigen, and the adjuvant Quil A [13] . Studies in various animals have influenza hemagglutinin (HA) in the serum (IgG) and at mucosal surfaces (sIgA) to prevent infection [4, 5] and induction of demonstrated improved humoral and cell-mediated (CTL and T helper) immune responses against model antigens (e.g., ovalvirus cross-reactive T lymphocytes (CD8 / or CD4 / ) or their cytokines to facilitate recovery from infection [5 -7] . Such bumin) and viral proteins, human immunodeficiency virus gp120, influenza HA, measles fusion protein, and herpes and characteristics should increase the proportion of vaccinated persons who are protected against infection with homologous inrabies viral proteins when vaccines were administered in the form of ISCOMs [14] . fluenza virus. Furthermore, the ability of a vaccine to induce cytotoxic T lymphocytes (CTL) that recognize highly conVarious properties of ISCOMs contribute to these increased immune responses. Compared with soluble antigens, ISCOMs are served epitopes within proteins across the various influenza virus subtypes may reduce the severity of illness and promote more rapidly distributed from the site of injection to the draining lymph nodes and spleen, where they persist for longer periods of faster recovery when the vaccine and circulating strains are serologically distinct.
time [15] . After subcutaneous immunization, antigens formulated as ISCOMs are taken up by a subset of splenic macrophages Various strategies are being investigated to develop parenterally administered influenza subunit vaccines that are more effidistinct from those that take up soluble antigens [16] . Within antigen-presenting cells, intact ISCOMs associate with intracellular lipid membranes and localize within the cytosolic and vesicular compartments [17] , enabling antigen processing for both class I JID 1998;177 (May) flu-ISCOMs, CTL, and Heterotypic Protection after solubilization with 1% nonionic detergent (Zwittergent 314;
In the present study, proteins from a recent vaccine strain Calbiochem, La Jolla, CA). The assays were done using A/Taiwan/ of an influenza H1 virus were formulated as ISCOMs and 24-well flat-bottomed tissue culture plates for 1 h at 37ЊC in 6% described in [20] ), and HA2 189-199 (IYSTVASSLVL, see [21] ), CO 2 . To each well was added 1 mL of overlay medium, comprising were synthesized on an automated peptide synthesizer (430A; ABI, 2% wt/vol Noble agar (Difco, Detroit), 0.2% D(/) glucose Norwalk, CT) using an optimized t-Boc chemistry according to (Sigma), 0.02% diethylaminoethyl dextran (Pharmacia, Quebec), the manufacturer's instructions. Synthetic peptides were cleaved 2.0% BME vitamins (ICN, Mississauga, Ontario), and 2 mg/mL from the resin, using hydrogen fluoride. The purity of the peptides TPCK trypsin (Sigma) in 21 Dulbecco's MEM (ICN). The plates exceeded 85% as judged by reverse-phase high performance liquid were incubated for 3 days at 37ЊC (5% CO 2 ), and then 1 mL of a chromatography. Amino acid analyses performed on a Pico-Tag 2% neutral red solution in PBS was added to each well and the system (Waters, Milford, ME) were consistent with the theoretical plates were incubated overnight. Stain was then aspirated, and the amino acid compositions.
plaques were counted and expressed as the mean logarithm of the Preparation of influenza ISCOMs. ISCOMs were prepared acnumber of plaque-forming units per milliliter. cording to the dialysis procedure of Lövgren and Morein [22] . In HAI assay. Blood was obtained before and after immunization brief, live influenza virus (A/Taiwan) grown in embryonated eggs via the orbital sinus vein of 6 randomly selected mice. Serum was purified from allantoic fluid by sucrose density gradient censamples were heated at 56ЊC for 30 min to inactivate complement. trifugation (20%-60% sucrose in PBS, 10,000 g for 60 min).
To 25 mL of serum was added 12.5 mL of trypsin (8 mg/mL) at Purified virus was solubilized with 2% Mega-10 (Bachem, Buben-56Њ C for 30 min. Samples were cooled to room temperature and dorf, Switzerland), and the insoluble cores were pelleted through incubated for a further 15 min with 112.5 mL of 0.001 M sodium 30% (wt/wt) sucrose. To 1 mL of supernatant was added 1 mg periodate. Excess periodate was neutralized with 225 mL of glyceach of phosphatidylcholine and cholesterol (Sigma, St. Louis) erol (0.6% in 0.14 M NaCl). Serially diluted antisera were tested and 5 mg of the adjuvant Quil A (Spikoside; Iscotec, Luleå, Swein duplicate for their ability to inhibit the agglutination of 1% den) per milligram of total viral protein as determined by the chick red blood cells by 4 HAU of A/Taiwan or A/Japan virus in Bradford assay [23] . The mixture was incubated for 2 h at room a standard HAI assay [25] . temperature, dialyzed against PBS, and layered onto a 10%-50%
Determination of CTL activity. For CTL studies, mice were (wt/wt) sucrose gradient. After being centrifuged (200,000 g for given a single immunization with either 1 mg of HA as A/Taiwan 18 h), fractions were collected for characterization.
flu-ISCOMs or 10 mg of HA as monovalent A/Taiwan subvirion Formation of ISCOMs was verified by negative-staining elecvaccine in 0.1 mL of PBS via the subcutaneous route. Ten days tron microscopy and analytical sucrose density centrifugation.
later, spleens were removed and splenocytes restimulated with live Cholesterol incorporation was determined using 3 H-cholesterol. virus. Spleen cells (2.5 1 10 7 ) were incubated at 37ЊC, 6% CO 2 , Fractions showing comigration of formed ISCOM particles, HA, in an upright flask in 20 mL of RPMI-10% fetal bovine serum and cholesterol were pooled and dialyzed extensively against PBS.
with the same number of gamma-irradiated (30 Gy [3000 rads]) The HA content of the flu-ISCOM fractions and commercial subvirion vaccine was determined by single radial immunodiffusion normal syngeneic spleen cells that were previously infected for 1 JID 1998; 177 (May) h at 37ЊC with A/Taiwan virus in allantoic fluid at 5000 HAU/8 from their lungs by day 4 after challenge. These mice were Cr at 50-100 mCi/10 6 cells in 96-detected in 20% of the animals (data not shown).
well V-bottomed tissue culture plates for 4-6 h at 37ЊC in 6%
Differences were also observed in the abilities of ISCOMs CO 2 . Target cells were either untreated, pulsed with 10 mM synand vaccine to protect mice against morbidity as determined Figure  1A -D show HAI titers in sera obtained 13 days after each data from two separate experiments are shown in table 1 and figure 3. One immunization with flu-ISCOMs (1 mg of HA) immunization and virus lung titers 4 days after challenge with homologous mouse-adapted influenza virus. After the first imgenerated CTL that lysed target cells infected with the homologous A/Taiwan influenza virus but not those infected with the munization, HAI activity in sera from mice that received 5 mg of HA as flu-ISCOMs was 10-fold higher than that in sera H3N2 virus A/Philippines, suggesting that the dominant CTL response was directed against proteins other than the highly from mice given 5 mg of HA as subvirion influenza vaccine or 0.5 mg of HA as flu-ISCOMs ( figure 1A ). These prechallenge conserved type-specific M1 protein and NP. This was consistent with the finding that spleen cells from BALB/c mice given HAI titers correlated with protection as determined by virus lung titers.
flu-ISCOMs failed to lyse target cells pulsed with a synthetic peptide NP147 -158(R0) containing the immunodominant HVirus could not be detected in the lungs of mice given one 5-mg dose of HA as flu-ISCOMs, indicating complete protec-2K d -restricted CTL epitope from NP, which is conserved among H1 and H3 type A viruses [26] . However, the same tion, whereas no protection was afforded by subvirion vaccine containing 5 mg of HA (figure 1B). Lower doses of flu-ISCOMs cell line efficiently killed target cells pulsed with the H-2K drestricted peptide, HA2 189 -199, located within the transmemwere not protective. Two immunizations with subvirion influenza vaccine were required to clear virus by day 4 after chalbrane domain of influenza H1 and H2 hemagglutinins [21] . The ability of this T cell line to lyse P815 cells (MHC class lenge ( figure 1D ). Serum HAI titers in mice immunized twice with 0.5 or 5 mg of subvirion vaccine ( figure 1C) were at least II negative) either infected with influenza virus or pulsed with a synthetic peptide (HA2 189 -199) representing a known 10-fold higher than those seen after primary immunization and gave partial (0.5-mg dose) and complete (5-mg dose) protection MHC class I -restricted CTL epitope suggests that CD8 / CTL are responsible for the lytic activity. Of interest, for mice immuagainst virus challenge ( figure 1D ).
flu-ISCOMs containing 0.5 mg of HA induced prechallenge nized with live A/Taiwan virus, the dominant CTL response was directed against the NP peptide 147 -158(R0) (52% net HAI titers comparable to those induced by 5 mg of HA as subvirion vaccine, while flu-ISCOMs at 5 mg of HA induced lysis) but not against the HA2 189 -199 epitope (9.2% net lysis). Accordingly, this T cell line lysed target cells infected HAI titers that were at least 20-fold higher than those from the same dose of HA as subvirion vaccine. Mice immunized twice with either H1 or H3 subtype viruses, reflecting the dominance of CTL that recognized the conserved NP epitope. Sufficient with 0.5 or 5 mg of HA as ISCOMs completely cleared virus homology exists within the amino acid sequence HA2 189 -phase of influenza virus infection [6] . Since in this study, fluISCOMs induced CTL capable of recognizing epitopes from 199 of influenza viruses of the H1 and H2 strains to enable recognition by HA-specific CTL generated from either virus both H1 and H2 influenza virus subtypes, experiments were done to determine whether mice immunized with A/Taiwan subtype [26] . Thus, the CTL line derived from BALB/c mice immunized with A/Taiwan (H1) flu-ISCOMs also lysed target H1 ISCOMs were protected against challenge with an H2 virus, A/Japan/56 (H2N2). ( figure 4A, B) . However, all mice given A/Taiwan flu-ISCOMs weight loss (13% of starting weight; figure 4D ). However, this weight loss was less than that observed for surviving mice also survived lethal challenge with A/Japan virus, whereas survival among animals given A/Taiwan vaccine or virus was immunized with A/Taiwan virus or subvirion vaccine (Ç30% loss of weight). The cross-protection induced by H1 fluonly 32% against A/Japan virus (figure 4C). Although mice given A/Taiwan flu-ISCOMs and challenged with A/Japan ISCOMs against challenge with the H2 virus did not correlate with the production of antibodies with cross-reactive HAI activwere fully protected against death, they did exhibit a transient / CTL. Data represent mean % lysis from triplicate determinations of representative experiment on spleen cell cultures pooled from 2 mice, tested at various effector-to-target ratios (E:T). ND Å not determined; HAU Å hemagglutination units. ity, since prechallenge sera of immunized animals failed to have been shown for detergent-extracted antigens from laboratory strains of influenza virus and for other proteins formulated inhibit agglutination of red blood cells by A/Japan influenza H2 virus (table 2) .
as ISCOMs tested in various species [14] . A characteristic feature of ISCOMs is their ability to induce In additional studies, A/Taiwan H1 flu-ISCOMs failed to protect mice against challenge with an H3 virus (data not antigen-specific, CD8 / class I MHC -restricted T cell responses against incorporated antigens, such as the human imshown). The ability of flu-ISCOMs to protect mice against H1 and H2 but not H3 influenza subtype viruses parallels the munodeficiency virus envelope protein [28] and ovalbumin [29] . In an earlier study, Jones et. al.
[30] demonstrated the differential recognition of these subtypes by CTL elicited by flu-ISCOMS ( figure 3) .
induction of influenza-specific CTL in mouse lungs following intranasal inoculation with flu-ISCOMs. However, the antigen specificity of these CTL was not determined. The present study Discussion is the first to report on the antigen specificity and virus cross- , previously shown to be recognized by involves both serum IgG and class I and class II MHC -restricted CTL [27] . CD8 / CTL arising from influenza virus infection [20, 21] . The immunodominant CTL response induced by live virus was CTL also appear to enhance the elimination of virus following heterotypic challenge, thereby reducing morbidity and moragainst NP147 -158(R0), a sequence that is conserved among H1, H2, and H3 virus subtypes [26] . In contrast, flu-ISCOMs tality [11] . In this study, we demonstrated that the ability of parenterally administered flu-ISCOMs to confer improved proelicited CTL that recognized HA2 189 -199, which is conserved among H1 and H2 but not H3 influenza viruses, but did tection in mice against infection with homologous virus correlated with the induction of higher serum HAI titers, reflecting not generate CTL against NP. This finding was unexpected since the amount of NP associated with the flu-ISCOM preparathe presence of antibodies specific for HA. At equivalent doses of HA, the serum HAI titers induced by ISCOMs containing tions was similar to the levels found in the subvirion vaccine as determined by polyacrylamide gel electrophoresis (data not proteins from a recent vaccine strain of influenza were at least 10-fold higher than those induced by vaccine. Similar findings shown). NOTE. Groups of BALB/c mice were immunized twice with A/Taiwan ISCOMs, subvirion vaccine, or live virus at days 0 and 21. Blood samples were obtained at days 13 and 34, and sera were tested for HAI activity against homologous A/Taiwan (H1N1) and heterotypic A/Japan (H2N2) viruses as described in Materials and Methods. Values represent mean titers for pooled sera. HA Å hemagglutinin.
Differences in the efficiency of processing of ISCOM-associfor live virus (or subvirion vaccine) that could contribute to the enhanced clearance of virus after infection. However, no ated NP and HA by antigen-presenting cells may explain the inability of flu-ISCOMs to induce CTL specific for NP in significant differences have been seen in the amount and type of Th1 and Th2 cytokines induced by virus and flu-ISCOMs BALB/c mice. NP may not be associated with ISCOMs in a manner that allows efficient cytoplasmic processing of the pro-(unpublished data) [18] . Another possible explanation for the differences in cross-protein for production of peptides that bind to MHC class I molecules. Viral membrane proteins, such as HA, that can associate tection induced by influenza virus and flu-ISCOMs is that the functional activities of CTL induced by flu-ISCOMs and live with phospholipid on the surface of the ISCOM particle may be more accessible to cytoplasmic proteases involved in provirus differ and may depend on their specificities for the HA and NP proteins, respectively. Of interest, data from a recent report cessing for class I presentation. Of interest, Weiss et al. [32] reported that lipidated but not native NP could be efficiently suggests that the resistance of certain mouse strains to Leishmania species may be dependent not only on the ability of the host to incorporated into ISCOMs, although such ISCOMs did not induce CTL in C3H (H-2 k ) mice. However, in recent studies, induce a Th1 response against the pathogen but also on the antigen specificity of the T cells generated [34] . CTL specific for HA we showed that NP-specific, class I MHC -restricted CTL are induced by H1 flu-ISCOMs in C57BL/6 (H-2 b ) mice (unpub- have been implicated in mediating cross-protection in mice given a recombinant HA2 fragment from influenza HA expressed as a lished data). Since there is no H-2 b binding motif within HA2 189 -199, this result suggests that in the appropriate mouse fusion protein.
Immunization with the HA2 protein of the H1 strain protected BALB/c mice against H1 and H2 but not H3 strain that is unable to mount a class I-MHC -restricted CTL response against HA, correct processing and presentation of strains of influenza virus [35] . Evidence for a protective role for NP-specific CTL has been ISCOM-associated NP for induction of CD8 / T cells can occur. We have shown that the ability of H1 flu-ISCOMs to induce less conclusive and may depend on the form of the antigen and the ability to induce long-term memory T cells [36] . For example, cross-reactive CTL against an epitope common to the transmembrane domains of the H1 and H2 influenza virus subtype while cross-protection has been clearly observed in mice immunized with cDNA encoding NP [11] , conflicting results have been hemagglutinins (not present in H3 viruses) correlated with protection against mortality and morbidity due to infection with reported for soluble NP [37, 38] and vaccinia-NP recombinants [39, 40] . Further studies are being done in the PMC Canada H1 and H2 but not H3 influenza viruses. However, since in the present study we have only classified the CTL responses laboratory to elucidate the effector mechanisms responsible for mediating cross-protection induced by flu-ISCOMs. on the basis of recognition of the immunodominant class I MHC -restricted CTL epitopes NP147 -158(R0) and HA2
The ability of flu-ISCOMs, compared with live virus or subvirion vaccine, to induce higher serum HAI titers and enhanced 189 -199, we cannot rule out the possibility that CTL specific for other epitopes within HA, NP, or other flu proteins may cross-protection against H2 influenza virus suggests that fluISCOMs may offer an advantage as an improved influenza also be contributing to the cross-protection observed. Studies are in progress at the PMC Canada laboratory to identify addivaccine in humans. ISCOMs have now been prepared with more defined fractions of Quil A suitable for use in humans tional CTL epitopes recognized by CTL induced by flu-ISCOMs. [41] . Furthermore, flu-ISCOMs protect mice against virus challenge when given intranasally [42] , offering the possibility of Mice given H1N1 influenza virus were poorly protected against challenge with an H2N2 virus. This result is surprising mucosal immunization strategies for future influenza vaccines. since live virus induced CTL specific for a known H-2K drestricted epitope of NP (NP147 -158[R0]) that is conserved among H1 and H2 viruses. One explanation for this finding is
